Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $52 at Baird
Tweet
Share
E-mailGet Alerts AMLX Hot Sheet
Price: $34.10 +0.41%
Rating Summary:
10 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 1 | New: 0
Rating Summary:
10 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 1 | New: 0
Join SI Premium – FREE
Baird analyst Joel Beatty raised the price target on Amylyx Pharmaceuticals inc. (NASDAQ: AMLX) to $52.00 (from $28.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Scout24 (G24:GR) (SCOTF) PT Lowered to EUR102.50 at Jefferies
- Jefferies Upgrades Rightmove Plc. (RMV:LN) (RTMVY) to Hold
- Vend Marketplaces (VEND:NO) PT Lowered to NOK285 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
